Compare TENX & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TENX | TWIN |
|---|---|---|
| Founded | 1967 | 1918 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.8M | 269.7M |
| IPO Year | 2001 | 1994 |
| Metric | TENX | TWIN |
|---|---|---|
| Price | $11.87 | $16.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $29.67 | N/A |
| AVG Volume (30 Days) | ★ 545.5K | 65.9K |
| Earning Date | 05-15-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.98% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.76 |
| Revenue | N/A | ★ $340,738,000.00 |
| Revenue This Year | N/A | $10.79 |
| Revenue Next Year | N/A | $8.43 |
| P/E Ratio | ★ N/A | $9.82 |
| Revenue Growth | N/A | ★ 15.45 |
| 52 Week Low | $5.34 | $7.06 |
| 52 Week High | $18.38 | $19.67 |
| Indicator | TENX | TWIN |
|---|---|---|
| Relative Strength Index (RSI) | 43.07 | 47.19 |
| Support Level | $10.87 | $16.46 |
| Resistance Level | $12.75 | $18.95 |
| Average True Range (ATR) | 0.67 | 1.08 |
| MACD | 0.06 | -0.06 |
| Stochastic Oscillator | 51.11 | 35.48 |
Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.